Getinge/Maquet CV Emerging As Mid-Cap Strategic With Atrium Acquisition
Executive Summary
At a time when the cardiovascular device industry is seeing less interest in M&A on the part of several large strategic players that formerly were major acquirers, a new mid-cap player appears to be emerging: Getinge's Maquet Cardiovascular division. The company recently announced its third major cardiovascular deal in the last five years with its $680 million acquisition of Hudson, NH-based Atrium Medical, which has a diversified cardiovascular products business.